文献速递神经肿瘤

小檗碱作为胶质母细胞瘤中5-ALA介导荧光的潜在增强剂:提高浸润性胶质瘤干细胞可检测性以优化5-ALA引导手术

Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery.
PubMed 文献 · J Neurosurg · 2024-03-08

该研究探讨小檗碱(BBR)能否增强胶质母细胞瘤(GBM)中5-氨基乙酰丙酸(5-ALA)介导的荧光,尤其是对胶质瘤干细胞(GSC)。体外实验显示BBR通过上调并激活ALAS1增强5-ALA荧光,GSC增强幅度高于胶质瘤细胞;动物实验中BBR增强荧光的灵敏度和特异度均为100%,且对瘤周正常脑组织无细胞毒性。

要点

  • BBR可增强5-ALA介导的PpIX荧光,对GSC的增强幅度高于胶质瘤细胞。
  • BBR通过上调并激活ALAS1、解除血红素负反馈抑制来增强荧光。
  • 动物实验中BBR增强荧光的灵敏度和特异度均为100%,且对瘤周正常脑组织无细胞毒性。

核心结论

  • BBR通过上调并激活ALAS1、解除血红素负反馈抑制来增强5-ALA介导的PpIX荧光。
  • BBR是临床已用药物且无副作用,作者预期其可显著增强荧光引导手术和光动力治疗。

研究设计与样本

  • 体外研究:用流式细胞术(FACS)分析BBR对胶质瘤和GSC中5-ALA荧光的影响,并分析血红素合成通路7种酶的mRNA表达。
  • 体内研究:在肿瘤移植小鼠中分析BBR增强荧光的可检测性和细胞毒性。

主要发现

  • 荧光显微镜显示,5-ALA联合BBR在GSC和非干细胞中的5-ALA荧光均比单用5-ALA更强烈。
  • FACS显示BBR较单用5-ALA大幅增强5-ALA荧光,且对GSC的增强幅度远高于胶质瘤细胞。
  • 7种酶中,BBR在所有细胞中均上调ALA合成酶1(ALAS1)的mRNA表达,并通过解除血红素对ALAS1活性的负反馈抑制来激活ALAS1。
  • 体内研究显示5-ALA联合BBR的5-ALA荧光显著强于单用5-ALA,BBR增强荧光的灵敏度和特异度均为100%。
  • BBR对肿瘤周围正常脑组织未显示任何细胞毒性。

临床怎么用

  • 作者预期BBR可显著增强荧光引导手术和光动力治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The prognosis of glioblastoma (GBM) correlates with residual tumor volume after surgery. In fluorescence-guided surgery, 5-aminolevulinic acid (ALA) has been used to maximize resection while avoiding neurological morbidity. However, not all tumor cells, particularly glioma stem cells (GSCs), display 5-ALA-mediated protoporphyrin IX (PpIX) fluorescence (5-ALA fluorescence). The authors searched for repositioned drugs that affect mitochondrial functions and energy metabolism, identifying berberine (BBR) as a potential enhancer of 5-ALA fluorescence. In this study, they investigated whether BBR can enhance 5-ALA fluorescence in GSCs and whether BBR can be applied to clinical practice as a 5-ALA fluorescence enhancer. METHODS: The effects of BBR on 5-ALA fluorescence in glioma and GSCs were evaluated by flow cytometry (fluorescence-activated cell sorting [FACS]) analysis. As 5-ALA is metabolized for heme synthesis, the effects of BBR on mRNA expressions of 7 enzymes in the heme-synthesis pathway were analyzed. Enzymes showing significantly higher expression than control in all cells were identified and protein analysis was performed. To examine clinical availability, the detectability and cytotoxicity of BBR in tumor-transplanted mice were analyzed. RESULTS: Fluorescence microscopy revealed much more intense 5-ALA fluorescence in both GSCs and non-stem cells with 5-ALA and BBR than with 5-ALA alone. FACS showed that BBR greatly enhanced 5-ALA fluorescence compared with 5-ALA alone, and enhancement was much higher for GSCs than for glioma cells. Among the 7 enzymes examined, BBR upregulated mRNA expressions of ALA synthetase 1 (ALAS1) more highly in all cells, and activated ALAS1 through deregulating ALAS1 activity inhibited by the negative feedback of heme. An in vivo study showed that 5-ALA fluorescence with 5-ALA and BBR was significantly stronger than with 5-ALA alone, and the sensitivity and specificity of BBR-enhanced fluorescence were both 100%. In addition, BBR did not show any cytotoxicity for normal brain tissue surrounding the tumor mass. CONCLUSIONS: BBR enhanced 5-ALA-mediated PpIX fluorescence by upregulating and activating ALAS1 through deregulation of negative feedback inhibition by heme. BBR is a clinically used drug with no side effects. BBR is expected to significantly augment fluorescence-guided surgery and photodynamic therapy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ohtsuka Y, Suehiro S, Inoue A, et al. Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery. J Neurosurg. 2024. PMID: 38457785. doi:10.3171/2023.12.JNS231506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。